Haemonetics Corp share price logo

Haemonetics Corp Share Price

NYSE: HAE

Mid Cap

$49.93

-1.09

(-2.14%)

as on

Haemonetics Corp Stock Performance

as on September 18, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $49.43
    $51.31
    downward going graph

    1.00%

    Downside

    2.76%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $49.43
    $94.99
    downward going graph

    1.00%

    Downside

    90.24%

    Upside

    downward going graph

Haemonetics Corp share price movements today

Previous Close
$51.02
Open
$51.30
Volume
1.2M
Day's Low - High
$49.43 - $51.31
52 Week Low - High
$49.43 - $94.99

Haemonetics Corp Historical Returns

1 Month Return
-5.97 %
3 Month Return
-28.7 %
1 Year Return
-33.94 %
3 Year Return
-34.94 %
5 Year Return
-39.73 %

Haemonetics Corp Stock Fundamentals & Key Indicators

Check Haemonetics Corp market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.4B

EPS (TTM)

4.5443

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.05%

PE Ratio (TTM)

15.28

Industry PE ratio

10.127857142857144

P/B Ratio

15.2752

PEG Ratio

1.2149

EBITDA

369.6M

Revenue (TTM)

1.3B

Profit Margin

12.14%

Return On Equity TTM

18.27%

Haemonetics Corp Stock Valuation

Track how Haemonetics Corp P/E has moved over time to understand its valuation trends.

Haemonetics Corp in the last 5 years

  • Overview

  • Trends

Lowest (15.76x)

June 30, 2025

Industry (10.13x)

September 18, 2025

Today (15.28x)

September 18, 2025

Highest (52.66x)

March 31, 2021

LowHigh

Today’s Price to Earnings Ratio: 15.28x

Haemonetics Corp vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Haemonetics Corp with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$2.4B-39.73%15.2812.14%
BUY$146.7B149.51%58.9213.55%
BUY$144.0B78.01%50.0212.25%
BUY$231.1B24.47%16.6632.43%
BUY$120.8B-12.63%26.0213.63%

Stock Returns calculator for Haemonetics Corp Stock including INR - Dollar returns

The Haemonetics Corp stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Haemonetics Corp investment value today

Current value as on today

₹70,635

Returns

₹29,365

(-29.37%)

Returns from Haemonetics Corp Stock

₹33,964 (-33.96%)

Dollar Returns*

₹4,598 (+4.6%)

Analyst Recommendation on Haemonetics Corp Stock

Based on 11 analysts

BUY

72.73%

Buy

27.27%

Hold

0.00%

Sell

Based on 11 analysts, 72.73% of analysts recommend a 'BUY' rating for Haemonetics Corp. Average target price of $78.64

Haemonetics Corp Share Price Target

Get share price movements and forecasts by analysts on Haemonetics Corp.

What analysts predicted

36.51%UPSIDE

Target Price

$78.64

Current Price

$49.93

Analyzed by

11 Analysts

Target

$78.64

Haemonetics Corp target price $78.64, a slight upside of 36.51% compared to current price of $49.93. According to 11 analysts rating.

Haemonetics Corp Stock's Interest Amongst Investors

Search interest for Haemonetics Corp Stock has decreased by -70% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-70% versus previous 30 day period

Haemonetics Corp Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
304
311
318
336
343
336
345
348
330
321
Gross Profit
156
167
170
177
171
174
187
193
193
180
Operating Income
35
53
35
45
51
39
51
59
71
55
EBITDA
59
76
35
69
78
68
80
88
99
78
Interest Expense
2
2
2
1
6
6
6
9
0
4
Depreciation
23
23
7
23
27
29
29
29
28
28
Income Before Tax
32
51
32
44
23
46
44
49
70
45
Income Tax Expense
3
10
7
12
3
8
10
12
12
11
Net Income
29
41
24
31
20
38
33
37
57
34
Net Profit Margin
9.65%
13.18%
7.83%
9.29%
5.93%
11.41%
9.79%
10.76%
17.54%
10.59%

Haemonetics Corp Annual Profit & Loss

All numbers in Millions USD

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Total Revenue
909
886
903
967
988
870
993
1,168
1,309
1,360
Gross Profit
405
378
411
417
484
397
505
615
691
748
Operating Income
-43
-19
56
83
153
57
80
156
164
221
EBITDA
45
70
153
192
264
142
178
249
265
337
Interest Expense
9
8
4
9
16
16
17
14
13
9
Depreciation
-
-
89
109
110
84
97
93
97
115
Income Before Tax
-53
-27
59
73
87
72
63
141
151
212
Income Tax Expense
2
-1
14
18
10
-6
20
26
34
44
Net Income
-55
-26
45
55
76
79
43
115
117
167
Net Profit Margin
-6.11%
-2.96%
5.04%
5.69%
7.74%
9.13%
4.37%
9.87%
8.98%
12.32%

Haemonetics Corp Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
41
24
31
20
38
33
37
57
34
Operating Cash Flow
19
99
0
64
-27
48
43
116
17
Investing Cash Flow
-15
-25
-268
-13
-139
-23
-17
18
-33
Financing Cash Flow
0
-7
109
-63
333
-74
1
-151
-2
Change in Cash
1
65
-157
-15
165
-45
21
-14
-13

Haemonetics Corp Annual Cash Flow

All numbers in Millions USD

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Income
-26
45
55
76
79
43
115
117
167
Operating Cash Flow
159
220
159
158
108
172
273
181
181
Investing Cash Flow
-73
-63
-116
-57
-425
-86
-143
-322
-161
Financing Cash Flow
-60
-120
-50
-131
367
-15
-100
38
108
Change in Cash
24
40
-10
-32
54
67
24
-105
127

Global Institutional Holdings in Haemonetics Corp

Funds
Holdings
BlackRock Inc
13.2%
Vanguard Group Inc
10.59%
Neuberger Berman Group LLC
9.03%
Wellington Management Company LLP
5.45%
T. Rowe Price Investment Management,Inc.
4.56%

Insights on Haemonetics Corp

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Boston Scientific Corp. has given 136.2% return, outperforming this stock by 171.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Boston Scientific Corp. has given 19.3% return, outperforming this stock by 53.2%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 57.98M → 34.03M (in $), with an average decrease of 41.3% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 3 quarters, 348.54M → 321.39M (in $), with an average decrease of 4.0% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, HAE stock has moved down by -6.6%

About Haemonetics Corp

haemonetics is the blood management company. our comprehensive portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood management continuum. collectively they help improve patient care, ensure patient safety, and reduce costs for blood and plasma collectors, hospitals, and patients around the world. our mission we believe that through proper blood management, our products and services can help our commercial plasma and blood center customers optimize their collection processes. we seek to help ensure a continual supply of high-quality plasma for biopharmaceuticals and blood components for therapeutic use at optimal costs, along with better blood management processes. working with our hospital customers, we seek to prevent a blood transfusion to the patient who doesn’t need one, or, if a transfusion is necessary, to ensure the transfusion of the right blood product, at the right time, in the right
OrganisationHaemonetics Corp
Headquarters125 Summer Street, Boston, MA, United States, 02110
IndustryHealth Technology
CEOMr. Christopher A. Simon
E-voting on sharesClick here to vote

Key Management of Haemonetics Corp

Name

Title

Mr. Frank W. Chan Ph.D.

Executive VP & COO

Mr. Rajeev Varma

Senior Vice President of Strategy & Corporate Development

Mr. James C. D'Arecca CPA

CFO, Executive VP & Financial Officer

Ms. Michelle L. Basil Esq., J.D.

Executive VP, General Counsel & Secretary

Mr. Roy Galvin

Executive VP & Chief Commercial Officer

Ms. Laurie A. Miller

Senior VP & Chief Human Resources Officer

Dr. Jan Hartmann M.D.

Senior VP & Chief Medical Officer

Mr. Christopher A. Simon

CEO, President & Director

Ms. Farris Maryanne Maunsell

VP, Chief Accounting Officer & Principal Accounting Officer

Ms. Olga Guyette

Senior Director of Investor Relations

FAQs

What is Haemonetics Corp share price today?

Haemonetics Corp share price today is $49.93 as on at the close of the market. Haemonetics Corp share today touched a day high of $51.31 and a low of $49.43.

What is the 52 week high and 52 week low for Haemonetics Corp share?

Haemonetics Corp share touched a 52 week high of $94.99 on and a 52 week low of $49.43 on . Haemonetics Corp stock price today i.e. is closed at $49.93,which is 47.43% down from its 52 week high and 1.01% up from its 52 week low.

What is Haemonetics Corp's market capitalisation today?

Haemonetics Corp market capitalisation is $0.00T as on .

How to invest in Haemonetics Corp Stock (HAE) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Haemonetics Corp on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Haemonetics Corp Shares that will get you 0.0300 shares as per Haemonetics Corp share price of $49.93 per share as on September 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Haemonetics Corp Stock (HAE) from India?

Indian investors can start investing in Haemonetics Corp (HAE) shares with as little as ₹87.816 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Haemonetics Corp stock (as per the Rupee-Dollar exchange rate as on ). Based on Haemonetics Corp share’s latest price of $49.93 as on September 18, 2025 at 1:29 am IST, you will get 0.2003 shares of Haemonetics Corp. Learn more about fractional shares .

What are the returns that Haemonetics Corp has given to Indian investors in the last 5 years?

Haemonetics Corp stock has given -39.73% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?